Pancreatic Cancer Research

ResearcherQingdao UniversityActive in the last 2 years

Zhan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7191-2910; OpenAlex author ID A5041851608. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and impairs gemcitabine response in pancreatic cancer. Last author DOI 10.1038/s41419-026-08586-4↗
  2. Design of nano-delivery systems for pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.canlet.2025.218098↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ruining Gong · 2 shared papers, 2025–2026 · strength 0.54
  2. Hao Sun · 1 shared paper, 2026 · strength 0.30
  3. Shunli Fu · 1 shared paper, 2025 · strength 0.24
  4. Chao Gao · 1 shared paper, 2025 · strength 0.24
  5. Qian Yu · 1 shared paper, 2025 · strength 0.24
  6. He Ren · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.